AI assistant
Sending…
Q32 Bio Inc. — Director's Dealing 2024
Mar 27, 2024
34891_dirs_2024-03-27_d7259205-4314-4112-b089-8b34640318dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-03-25
Reporting Person: LAPORTE KATHLEEN (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | Stock Option (Right to Buy) | $16.82 | A | 12767 | Acquired | 2034-03-24 | Common Stock (12767) | Direct |
Footnotes
F1: One-third of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
More from Q32 Bio Inc.
Capital/Financing Update
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Capital/Financing Update
2026
Apr 24
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Feb 27